Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64.3M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
14.5M
-
Shares change
-
+14.5M
-
Total reported value, excl. options
-
$186M
-
Value change
-
+$186M
-
Number of buys
-
21
-
Price
-
$13.25
Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q2 2021
21 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q2 2021.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.5M shares
of 64.3M outstanding shares and own 22.56% of the company stock.
Largest 10 shareholders include FMR LLC (3.12M shares), Abingworth LLP (2.96M shares), Sofinnova Investments, Inc. (2.91M shares), CITADEL ADVISORS LLC (1.74M shares), KPCB XVI Associates, LLC (1.34M shares), Octagon Capital Advisors LP (1.13M shares), Alphabet Inc. (945K shares), MILLENNIUM MANAGEMENT LLC (81.5K shares), Parkman Healthcare Partners LLC (75.6K shares), and VANGUARD GROUP INC (52.3K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.